Drug Shortage Report for TEVA-VARENICLINE
| Report ID | 89875 |
| Drug Identification Number | 02426226 |
| Brand name | TEVA-VARENICLINE |
| Common or Proper name | VARENICLINE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VARENICLINE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 56 |
| ATC code | N07BA |
| ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2019-09-30 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2020-08-03 |
| Shortage status | Resolved |
| Updated date | 2020-08-04 |
| Company comments | Inventory is being managed |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-08-04 | French | Compare |
| v3 | 2020-08-04 | English | Compare |
| v2 | 2019-07-24 | French | Compare |
| v1 | 2019-07-24 | English | Compare |
Showing 1 to 4 of 4